RAISA MORGAN: Open Payments
NPI 1841941465 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 16 payments from 12 companies in 2025. Trend: 2023 $95 · 2024 $0 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| ABIOMED | 2 | $94 |
| Boston Scientific Corporation | 1 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Novo Nordisk Inc | 1 | $27 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Stryker Corporation | 1 | $17 |
Products named: WAINUA, General - Therapies, JARDIANCE, LEQVIO, VERQUVO, Wegovy, GORE VIABAHN VBX Balloon Expandable Endo, OPSYNVI.
Industry payments across GA — which companies pay providers there.
